You are here

Article Text

Article menu
Download PDFPDF
Gastrointestinal motility
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans
  1. E P Bouras,
  2. M Camilleri,
  3. D D Burton,
  4. S McKinzie
  1. Gastroenterology Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
  1. Dr M Camilleri, Mayo Clinic, GI Unit—Alfred 2–435, 200 First St SW, Rochester, MN 55905, USA.

Abstract

BACKGROUND Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chemical class of benzofurans, with gastrointestinal prokinetic activities in vitro.

AIMS To evaluate the effects of prucalopride on gastrointestinal and colonic transit.

METHODS A validated scintigraphic technique was used to measure gastrointestinal and colonic transit over 48 hours in 50 healthy volunteers. For seven days, each subject received a daily dose of 0.5, 1, 2, or 4 mg prucalopride, or placebo in a double blind, randomised fashion. The transit test was performed over the last 48 hours.

RESULTS There were significant accelerations of overall colonic transit at 4, 8, 24, and 48 hours (p<0.05) and proximal colonic emptying t1/2 (p<0.05). The 0.5, 2, and 4 mg doses of prucalopride were almost equally effective and accelerated colonic transit compared with placebo. Prucalopride did not significantly alter gastric emptying (p>0.5) or small bowel transit (overall p=0.12). The medication appeared to be well tolerated during the seven day treatment of healthy subjects.

CONCLUSION Prucalopride accelerates colonic transit, partly by stimulating proximal colonic emptying, but does not alter gastric or small bowel transit in healthy human subjects. Prucalopride deserves further study in patients with constipation.

  • benzofuran
  • prucalopride
  • motility
  • transit
  • colon
  • gastrointestinal

  • Abbreviations

    5HT
    5-hydroxytryptamine
    WGTT
    whole gut transit time

    • https://doi.org/10.1136/gut.44.5.682

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    • Abbreviations

      5HT
      5-hydroxytryptamine
      WGTT
      whole gut transit time
      • View Full Text